ArticleBMJ open2021

Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption.

Martin Lund Kårhus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.